Evidence map›Paper›PMID 30341607›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2019

Assays for Light Chain Amyloidosis Formation and Cytotoxicity.

Luis M Blancas-Mejia, Pinaki Misra, Christopher J Dick, Marta Marin-Argany, Keely R Redhage, Shawna A Cooper, Marina Ramirez-Alvarado

Abstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Early events in light chain aggregation at physiological pH reveal new insights on assembly, stability, and aggregate dissociation.Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis · 2021
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Luis M Blancas-MejiaDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA.
Pinaki MisraDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA.
Christopher J DickDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA.
Marta Marin-ArganyInstitute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain.
Keely R RedhageDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA.
Shawna A CooperDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA.
Marina Ramirez-AlvaradoDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA. ramirezalvarado.marina@mayo.edu.

Funding

Mechanisms of Aggregation in Light Chain AmyloidosisR01GM071514 · NIGMS · MAYO CLINIC ROCHESTER · PI RAMIREZ-ALVARADO, MARINA · 2006 to 2014
$2.8M
Cellular, kinetic, and structural mechanisms of toxicity in light chain amyloidosisR01GM128253 · NIGMS · MAYO CLINIC ROCHESTER · PI RAMIREZ-ALVARADO, MARINA · 2018 to 2021
$1.6M
NIGMS NIH HHS R01 GM071514NIGMS NIH HHS R01 GM128253
6 · The paper itself

Abstract

Common biophysical techniques like absorption and fluorescence spectroscopy, microscopy, and light scattering studies have been in use to investigate fibril assembly for a long time. However, there is sometimes a lack of consensus from the findings of an individual technique when compared in parallel with the other techniques. In this chapter, we aim to provide a concise compilation of techniques that can effectively be used to obtain a comprehensive representation of the structural, aggregation, and toxicity determinants in immunoglobulin light chain amyloidosis. We start by giving a brief introduction on amyloid assembly and the advantages of using simple and readily available techniques to study aggregation. After an overview on preparation of protein to set up parallel experiments, we provide a systematic description of the in vitro techniques used to study aggregation in AL protein. Additionally, we thoroughly discuss the steps needed in our experience during the individual experiments for better reproducibility and data analysis.

Indexed as

Biological AssayAmyloidAmyloidogenic ProteinsAmyloidosisApoptosisBenzothiazolesChromatography, GelChromatography, High Pressure LiquidCircular DichroismDynamic Light ScatteringImmunoglobulin Light ChainsParticle SizeSpectrometry, FluorescenceAmyloidAmyloidogenic ProteinsBenzothiazolesImmunoglobulin Light Chainsthioflavin TAmyloid formationAmyloidosisCaspase assayCell viabilityElectron microscopyImmunoglobulin light chainSedimentation assayThioflavin T

Identifiers

PMID30341607
PMCPMC6581042

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.